Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

Abstract Background The humanized anti-CGRP monoclonal antibody eptinezumab has been evaluated in five large-scale clinical trials conducted in patients with migraine. This integrated analysis was conducted to evaluate the comprehensive safety and tolerability of eptinezumab in patients with migrain...

Full description

Bibliographic Details
Main Authors: Timothy R. Smith, Egilius L. H. Spierings, Roger Cady, Joe Hirman, Barbara Schaeffler, Vivienne Shen, Bjørn Sperling, Thomas Brevig, Mette Krog Josiassen, Elizabeth Brunner, Loan Honeywell, Lahar Mehta
Format: Article
Language:English
Published: BMC 2021-03-01
Series:The Journal of Headache and Pain
Subjects:
Eptinezumab
Episodic migraine
Chronic migraine
Safety
Tolerability
Online Access:https://doi.org/10.1186/s10194-021-01227-5

Internet

https://doi.org/10.1186/s10194-021-01227-5

Similar Items